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Abstract
Objective: The objective of this selective EBM review is to determine whether or not
curcuminoids are effective in improving physical function in patients with knee osteoarthritis.
Study Design: Review of a double-blind randomized control trial, a randomized control trial, and
a randomized single-blind placebo-controlled trial.
Data Sources: The articles were found on PubMed and selected based on the relevance to the
clinical question and if they were focused on patient-oriented evidence that matters (POEM).
Outcomes Measured: The outcomes were based solely on function measures using a patient rated
WOMAC scale (WOMAC function) (patient satisfaction of treatment on a 5-category scale
(high, moderate, little, same, or dissatisfaction), an investigator based Clinician Global
Impression of Change (CGIC), a 6-minute walk distance), and time spent during a 100-meter
walk and going up and down a flight of stairs. This study focuses on the WOMAC scale and time
spent during a 100-meter walk.
Results: Kuptniratsaikul, et. al (2014) found that C. domestica extracts were just as effective as
Ibuprofen in treating knee OA and had a similar side effect profile, with less GI side effects than
ibuprofen. Kuptniratsaikul, et. al (2009) also found that C. domestica extracts seemed just as
effective and safe at treating knee OA as ibuprofen, but was not statistically different enough to
be definitive. Madhu, et. al found NR-INF-02 to be an acceptable and tolerable option in the
treatment of knee OA.
Conclusions: Based on these three randomized, controlled clinical trials, the efficacy of
curcuminoids on knee osteoarthritis is likely to be an effective alternative treatment method to
improve functionality. The populations studied in these trials were not large and should be
considered and addressed in future studies.
Key Words: Turmeric, arthritis, randomized controlled trial
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Introduction
Worldwide, knee osteoarthritis (OA) is a major public health concern, being the most
common degenerative joint disorder in the elderly.1 In osteoarthritis, cartilage between the bones
begins to break down leading to pain, swelling, and difficulty moving the effected joint.2 Over
time, OA worsens causing bony spur formation, pieces of broken off bone or cartilage to float in
the joint space, and inflammation.2 This inflammation further damages the cartilage.2 In the final
stages of OA, the cartilage has been completely worn out which causes bone to rub against bone
resulting in increased pain, inflammation, and damage, and decreased joint function.2
The symptoms of knee OA are secondary to the degradation of collagen and include a
gradual onset of pain and stiffness in the joint, most likely occurring first thing in the morning or
soon after resting.2 Symptoms also include swelling that gets worse with extended activity,
limited ROM that increases after movement, pain that can worsen at the end of the day, and
crepitation that occurs when joint is bent.2 There are many different causes and risk factors of
OA. The first is an increased weight/BMI that can cause cartilage cushions to break down faster.2
Injury or overuse of a joint can also cause OA.2 Although the exact genetic cause is unknown,
scientists believe that there is a rare defect in the production of collagen or a defect in the way
bones fit together.2
Knee OA is a common joint disorder affecting many people and incurring increasingly
high healthcare costs every year. It affects approximately 30.8 million Americans.3 It is also
estimated that 1 in 2 people in the US, at some point in their lives, will develop knee OA
symptoms.4 Most patients spend approximately 13 years with symptomatic knee OA before
receiving a total knee arthroplasty (TKA), instead supplementing with pharmacologics.4 These
patients had an average of 6 more yearly MD visits and 3.8 more non-MD visits than patients
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without knee OA.5 Eventually, most patients with knee OA will need to receive a TKA, with an
average of 658,000 Americans receiving one every year resulting in a 28% increase in hospital
stays.4,5 As a result of increased visits, pharmacologic supplementation, TKAs, and associated
hospital stays, it is estimated that knee OA contributes in excess of 27 billion dollars in
healthcare costs every year.4 In 2011 alone, Medicare reimbursed healthcare systems 3.5 billion
dollars for TKAs, which is a higher cost than heart failure, spinal fusions, or coronary stents.4
There are various treatment methods that can be used to increase functionality in patients
with knee osteoarthritis. Non-pharmacologic methods include weight management, stretching,
PT/OT, and assistive devices.2 Furthermore, you can do various physical activities, including
strengthening, ROM exercises, and aerobic exercises.2 Pharmacologic treatments can include
pain and anti-inflammatory medications like analgesics, NSAIDs, corticosteroids, or hyaluronic
acid.2 It can also include natural and alternative methods like supplements, acupuncture,
acupressure, and massage.2 Most patients will need a TKA at some point in their struggle with
knee OA.2
Although there are many different treatment options available to treat the decreased
functionality that comes with knee OA, some of the treatment options have increased side effect
profiles. Also, some patients are not able to implement available treatment modalities due to
other comorbid conditions and the effects certain medications might have on them. 60-90% of
patients with knee OA are interested in alternative methods of medicine, and curcuminoids fall
into that category in the treatment of knee OA.4 Curcuminoids inhibit the effect of substances
found in the inhibitory pathway (lipoxygenase, cyclooxygenase, phospholipase, etc.) and proinflammatory cytokines (IL-1 beta, IL-8, TNF-alpha, etc.).1
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Objective
The objective of this selective EBM review is to determine whether curcuminoids are
effective in improving physical function in patients with knee osteoarthritis.
Methods
Criteria used for selection of studies for this systematic review is based on specific
populations, interventions, comparisons, outcomes measured, and the type of study that was
done. The population studied was any patient, male or female, greater than 40 years of age with
knee osteoarthritis. None of the patients had an allergy to curcuminoids or co-existing conditions
that could impede the success of the trial. The interventions studied were the use of curcuminoids
versus a placebo, ibuprofen, or glucosamine sulfate when comparing the effective treatment of
knee OA. The outcome measured was the improvement of physical function with the use of
curcuminoids using methods that centered around patient-oriented evidence that matters
(POEM). The studies used in this systematic review include a double-blind randomized control
trial, a randomized control trial, and a randomized single-bind placebo-controlled trial.
Research for this systematic review was found using PubMed. The studies were
randomized controlled trials and the articles were published in peer-reviewed journals within the
last 10 years. All articles were written in the English language. The keywords used when
searching for these articles were “turmeric”, “arthritis”, and “randomized controlled trial”. The
articles were selected for this systematic review based on the relevance to the objective. This
includes patients that were greater than 40 years old who had been diagnosed knee OA and
whether or not the articles’ outcomes were based on patient-oriented evidence that matters. The
exclusion criteria excluded papers that included patients less than 40 years old, studies that were
not randomized or controlled, and studies that had outcomes that were not based on patient-
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oriented evidence that matters. The statistics used or reported in these studies were change in the
mean baseline. The data from the articles was analyzed using p-values and Confidence Intervals
using continuous data to analyze the efficacy of curcuminoids in improving physical function in
patients with knee osteoarthritis compared to placebos or alternative treatment methods.
Outcomes Measured
The outcome that was measured in these studies was a change in physical function in
patients with knee osteoarthritis. Kuptniratsaikul et. al (2014) assessed physical function in the
patients using a modified Thai version of the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) scale, with a focus on the WOMAC function subscale.1 The
scale has a range from 0 to 10, with a higher score representing worse knee function.1 They also
used a 6-minute walk distance to evaluate function.1 These assessments were completed at weeks
2 and 4 during treatment follow-up.1 At the end of the trial, patients were asked to complete a
global assessment and satisfaction survey.1 The patients were also asked to report any adverse
events that occurred throughout the study, recorded as any new symptoms the patients
experienced.1
Kuptniratsaikul, et. al (2009) assessed physical function in the patients based on time
spent on a 100-meter walk and time spent going up and down a flight of stairs (10 steps).6 For
both exercises, the time was measured using a digital stopwatch that had a resolution within
0.001 seconds.6 Each participant was analyzed by the same assessor at every visit, and all
patients completed the exercises at the same location.6 The patients were assessed at weeks 2, 4,
and 6.6 Throughout the study, patients reported any adverse events as either new symptoms
experienced or a change in lab profiles completed at week 0 and week 6 that included a complete
blood count, liver function, and renal function.6 At the end of the trial during the 6 week follow-
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up, patients were asked to complete a patient satisfaction survey evaluated by a 5-category scale:
high, moderate, little, same, or dissatisfaction.6
Madhu, et. al assessed physical function in the patients based on the Likert Version-3.0 of
the WOMAC, which was modified for Indian use.4 The WOMAC scale had 24 questions, with
questions 8-24 focusing on physical functional difficulty.4 The responses were quantitative: 0
being none, 1 being mild, 2 being moderate, 3 being severe, and 4 being extreme.4 The highest
score possible was a 96.4 This was completed on days 0, 21, and 42.4 The Clinician Global
Impression of Change (CGIC) was assessed by clinical examination by a designated orthopedic
consultant and had an emphasis on the presence or absence of the limitation of movement,
crepitus, muscle wasting, and subluxation of joint.4 This was completed on days 21 and 42 of
trial follow-up.4 At the end of the trial, the acceptability of medications by study patients
wherever available was evaluated as 0-3: 0 being not acceptable, 1 being good, 2 being better,
and 3 being best.4 Patients were also asked to report any adverse events throughout the trial.4
Three articles were chosen for this systematic review. Table 1 represents the demographics and
characteristics of each study that was selected.
Results
Three randomized, controlled trials were chosen for this systematic review to determine
the efficacy and safety of curcuminoids for the improvement of function in patients with knee
osteoarthritis. The Kuptniratsaikul, et. al (2014) study used continuous data that was not
convertible into dichotomous form.1 The data was analyzed using a per-protocol analysis.1 The
Kuptniratsaikul, et. al (2009) study also used continuous data that was not convertible into
dichotomous data.6 Like the previous study, the data was not based on an intention-to-treatanalysis, but instead it was based on a per-protocol analysis.6 The Madhu, et. al study also used
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Table 1: Demographics & Characteristics of included studies
Study

Type
RCT

#
Pts
367

Age
(yrs)
≥ 50

Kuptniratsikul,
2014

Kuptniratsikul,
2009

RCT

107

> 50

Madhu,
2013

RCT

120

> 40

Inclusion
Criteria
Pts who had
primary knee
OA with a
numerical pain
scale >5/10 and
≥50 y.o.

Exclusion
W/D
Criteria
Pts who had
36
abnormal liver or
kidney function,
history of peptic
ulcer, allergy to
curcumin or
ibuprofen, or
unable to walk
Pts who had
Pts who had
16
primary knee
peptic ulcers,
OA, knee pain,
hepatobiliary
radiographic
tract disease, or
osteophytes and known allergy to
1 of the
curcumin or
following: 1) age
ibuprofen
> 50 years, 2)
morning stiffness
30 mins in
duration, 3) and
crepitus on
motion
Pts who were
Pts who had
10
either gender, >
medical or
40 y.o., clinical
arthritic
evidence
conditions
confirming
confounding
diagnosis of
evaluation of
knee OA,
knee OA,
duration of pain
Primary
at least 6 months
predominant
on majority of
patella-femoral
days during
disease, history
preceding
of clinically
months, and
significant
showing
trauma/surgery
radiological
to affected knee,
evidence of knee and co-existing
OA Grade 2 or
disease that
Grade 3
could preclude
the successful
completion of
the trial

Interventions
C. domestica
extracts 1,500
mg/day VS.
Ibuprofen
1,200 mg/day

C. domestica
extracts 2
g/day VS.
Ibuprofen 800
mg/day

NF-INF-02
500 mg BID
VS.
Glucosamine
Sulfate (GS)
750 mg BID
VS.
Combo of
NF-INF-02
and GS
VS. Placebo
400 mg BID
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continuous data that was not convertible into dichotomous data; however, it was based on an
intention-to-treat analysis.4 All three studies analyzed the measured outcomes based on change in
mean baseline of improvement of physical function of the patients.
In the Kuptniratsaikul, et. al (2014) study, 367 patients were initially included in the
study based on inclusion and exclusion criteria. 331 patients were able to finish the study with 36
lost to follow-up (Table 1). This meant that 171 patients were left in the C. domestica extracts
group and 160 were left in the ibuprofen group.1 The patients either received 1,500 mg/day of C.
domestica or 1,200 mg/day of ibuprofen, with both treatment options being made to look
identical.1 Patients were asked to take 2 capsules after meals three times a day for 4 weeks and to
not use any other medications during the study, except recorded Tramadol as a rescue medication
for severe pain.1 The outcomes were evaluated at weeks 2 and 4 by the same assessor at each
site.1 At week 4, the WOMAC function scale showed a non-inferiority of C. domestica extract as
a treatment when compared to ibuprofen (p-value = 0.010) (Table 2).1 The baseline WOMAC
function score was not significantly different between the two groups at the beginning of the
study (Table 2).1 One hundred and twenty patients (29.7% in the C. domestica group and 35.7%
in the ibuprofen group) reported adverse events including dyspepsia, abdominal pain, nausea,
loose stools, and pitting edema.1 C. domestica had lower GI side effects overall than ibuprofen.1
Table 2: Mean WOMAC Function Score at the Beginning and End of Treatment1
C. domestica extracts
Ibuprofen
(n=171)
(n=160)
WOMAC functions (beginning)
5.3±2.0
5.1±1.8
WOMAC function
3.41±2.09
3.26±2.05
(end, adjusted by week 0)

P-value
0.440
0.010

When looking at the WOMAC function score, the change from week 0 to week 4 was an
improvement of 3.41±2.09. This is a large improvement since the scale was based on a 0-10
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measure, despite the standard deviation being wide. The confidence interval was at 95% and the
p-value was ≤ 0.05 at 0.01. Keeping these statistics in mind, it can be confidently said that C.
domestica is a statistically significant treatment and would be a non-inferior treatment in a large
population.
In the Kuptniratsaikul, et. al (2009) study, 107 patients were initially included in the
study based on inclusion and exclusion criteria. 91 patients were able to finish the study with 16
lost to follow-up (Table 1). This meant that 45 patients were left in the C. domestica extracts
group and 46 were left in the ibuprofen group.6 The patients either received 500 mg four times a
day of C. domestica extracts or 400 mg twice a day of ibuprofen, with instructions not to use any
other medicines or herbs.6 The outcomes were evaluated at weeks 0, 2, 4, and 6 by the same
assessor at each site.6 At week 6, the time spent on a 100-meter walk suggests that C. domestica
extracts might be as effective as ibuprofen in improving function, but the values were not
statistically different (p-value = 0.16) (Table 3).6 Thirty-nine patients (16 in the C. domestica
group and 23 in the ibuprofen group) reported adverse events including dyspepsia, dizziness,
nausea and vomiting, and loose stools.6 C. domestica had lower GI side effects overall than
ibuprofen.6
Table 3: Change in Time Spent Walking 100-meters Between the Beginning and End of
Treatment6
C. domestica extracts
Ibuprofen
Difference of Change Score P-value
(n=45)
(n=46)
(95% CI)
Change Score
10.1±16.8
5.0±16.9
5.07
0.16
(sec)
(-2.09 to 12.23)
When looking at the time spent walking 100-meters, the difference in mean change
scores from week 0 to week 6 was a difference of 5.07 seconds with a 95% confidence interval
between -2.09 and 12.23. This is a small improvement since the C. domestica group only
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improved 5 seconds more than the ibuprofen group and the confidence interval is wide. If the
confidence interval was narrowed and the difference in change score had increased, it would be a
large improvement. The confidence interval was at 95% and the p-value was > 0.05 at 0.16.
When interpreting the statistics, it can be confidently said that the treatment was not statistically
significant and may not be a good treatment option in a large population.
In the Madhu, et. al study, 120 patients were initially included in the study based on
inclusion and exclusion criteria. 110 patients were able to finish the study with 10 lost to followup (Table 1). This meant that 29 patients were left in the NR-INF-02 group, 28 in the
glucosamine sulfate (GS) group, 24 in the NR-INF-02 + GS group, and 29 in the placebo group.4
The NR-INF-02 group received one 500 mg capsule twice a day, the GS group received two 375
mg capsules twice a day, the NR-INF-02 + GS received one 500 mg capsule twice a day and two
375 mg capsules twice a day (respectively), and the placebo group received one 400 mg capsule
twice a day.4 The outcomes were evaluated at days 0, 21, and 42.4 Acetaminophen tablets 2,0004,000 mg per day were allowed as a rescue medication, except 24 hours before clinical
examination of the knee joint.4 At day 42, the WOMAC score showed a significantly higher
reduction in the NR-INF-02 groups when compared to the placebo and NS-INR02 + GS group
(p-value < 0.05); however, there were so significant difference when compared to the GS group
(Table 4).4 The baseline WOMAC function score was not significantly different between the four
groups at the beginning of the study (Table 4).4 Thirteen patients (2 in the NR-INF-02 group, 5
in the GS group, 4 in the NR-INF-02 + GS group, and 2 in the placebo group) reported adverse
events including dyspepsia, fever, sore throat, pedal edema, generalized body pain, and cough.4
NR-INF-02 had the least number of adverse events during the trial.4
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Table 4: Effect of Treatment on WOMAC over 21st Day and 42nd Day Follow-Up
NR-INF-02
Glucosamine
NR-INF-02 +GS
Placebo
(n=29)
(n=24)
(n=24)
(n=29)
Baseline
54.97±9.85
58.30±12.73
60.73±11.47
57.23±9.63
21st Day1
36.67±16.08a,b
44.17±15.77
47.31±19.16
52.23±9.63
nd
2
a, b
42 Day
27.14±16.13
34.92±19.48
36.21±24.74
47.90±12.59
1

Significantly different from baseline to first follow-up (p < 0.01); 2 Significantly different from
baseline to second follow-up (p < 0.01); a Significantly different from Placebo (p <0.05); b Significantly
different from NR-INF-02 + GS (p<0.05)

When looking at the WOMAC score, the score was significantly different on day 42 than
when compared to the baseline (p-value < 0.01). The confidence interval was not given, but the
p-value was < 0.01 and was significantly different than the NR-INF-02 + GS and placebo groups
with a p-value of < 0.05. Keeping these statistics in mind, it can be confidently said that NFINR-02 is a statistically significant treatment and would be an acceptable and tolerable treatment
option in a large population.
Discussion
This systematic review compares three randomized, controlled clinical trials, and two out
of three of them found that curcuminoids are statistically effective at improving physical
function in people with knee osteoarthritis.1, 4, 6 Kuptniratsaikul, et. al (2014) found significant
improvement in the WOMAC function subscale.1 Kuptniratsaikul, et. al (2009) did not find
significant improvement in the time it took to walk 100-meters.6 Madhu, et. al found significant
improvement in the WOMAC score.4
For a long time, curcumin has been used as a spice and coloring agent in Thai curry
powders.1 In Ayurvedic and Chinese medicine, it has been used as an anti-oxidant, for its antiinflammatory properties, to aid in digestion, to treat liver problems and skin disease, and to aid in
wound healing.7 In food, curcumin is considered safe; however, large amounts for long periods
of time can cause stomach upset and ulcers.7 It can also lower blood sugars, so should be used
with caution in diabetics.7 Furthermore, it can cause blood thinning, so it should be discontinued
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at least two weeks before a planned surgery.7 It should be used with caution if one is taking:
blood thinners, diabetic medicines, proton pump inhibitors, or antacids/antihistamines.7
Kuptniratsaikul, et. al (2014) mentioned that they were concerned about the dosage of
ibuprofen used in the active control group.1 They chose a 1,200-mg dosage instead of a higher
dosage of 1,800 mg at the recommendation of a rheumatologist due to the smaller body habitus
of the Thai population.1 Kuptniratsaikul, et. al (2009) mentioned that the wide range of 95% CI
indicated that their study had an inadequate sample size.6 They also had concerns about the
amount of C. domestica dosages needed throughout the day and the low dosage of ibuprofen
used, which was 400 mg twice daily.6 They suggested another study with a bigger sample size
and increased dosage of ibuprofen.6 Madhu, et. al considered a few limitations in their study
including: 1) small sample size; 2) study being single blind; 3) short duration of treatment; and 4)
subjective scales.4 They suggested that future studies should include a large sample group and a
longer duration of treatment.4
Conclusion
Based on these three randomized, controlled trials, the efficacy of curcuminoids is
inconclusive, with only two out of the three studies finding statistically significant improvement
in physical function when using curcuminoids as treatment.1, 4, 6 In future studies, it would be
appropriate to have larger sample sizes and longer duration of studies. If researchers focused on
these two areas, they would give a more accurate portrayal of and validate the efficacy of
curcuminoids in improving physical function in the general population of patients with knee
osteoarthritis.

References
1. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of
curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis:
A multicenter study. Clin Interv Aging. 2014;9:451-458. doi: 10.2147/CIA.S58535 [doi].
2. Osteoarthritis. Arthritis Foundation Web site. http://www.arthritis.org/aboutarthritis/types/osteoarthritis/. Accessed October 3, 2017.
3. Arthritis Foundation. Arthritis by the
Numbers. https://www.arthritis.org/Documents/Sections/About-Arthritis/arthritisfacts-stats-figures.pdf ed. Arthritis Foundation; 2015:9-15.
4. Madhu K, Chanda K, Saji MJ. Safety and efficacy of curcuma longa extract in the
treatment of painful knee osteoarthritis: A randomized placebo-controlled
trial. Inflammopharmacology. 2013;21(2):129-136. doi: 10.1007/s10787-012-0163-3
[doi].
5. Wright EA, Katz JN, Cisternas MG, Kessler CL, Wagenseller A, Losina E. Impact of
Knee Osteoarthritis on Health Care Resource Utilization in a US Population-Based
National Sample. Medical Care. 2010;48(9):785791.doi:10.1097/mlr.0b013e3181e419b1 [doi].
6. Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, Wattanamongkonsil L,
Thamlikitkul V. Efficacy and safety of curcuma domestica extracts in patients with knee
osteoarthritis. J Altern Complement Med. 2009;15(8):891-897. doi:
10.1089/acm.2008.0186 [doi].
7. Ehrlich SD. Turmeric. University of Maryland Medical Center Web
site. http://www.umm.edu/health/medical/altmed/herb/turmeric. Published 1/1/2017.
Updated 2017. Accessed October 10, 2017.

